To further confirm that SHARP1 inhibits tumor angiogenesis, we performed MVD analysis on four cases from each grade of EEC (G1–G3) and four cases of non-EEC specimens (one case of clear cell EC and three cases of papillary serous EC), while normal endometrium tissues were used as a control. Here, BHLHE41 is linked to neoplasm.